NYSE: MED
Medifast, Inc.
Industrials · Personal Products & Services
After hours: $11.44(0%) · as of 7:34 PM ET
Market Cap
$127.20M
52w High
$14.67
52w Low
$9.22
P/E
-4.91
Volume
69.14K
Outstanding Shares
11.12M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 12.2% over the last year. Revenue declined 34.03% over the trailing twelve months. Operating margin moved from 0.1% to -5.46%. Free cash flow grew 265.69% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/FCF, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at -5.46%. Revenue declined 34.03% — this read reverses if that trend stabilizes. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
4
Buy
6
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 2, 2026
Q4 FY26 · EPS est -$0.35 · Revenue est $71.3M
View